Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Trimesta in relapsing-remitting multiple sclerosis patients (Phase II)
Daclizumab-induced adverse events in multiple organ systems in multiple sclerosis.
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
The two faces of neuromyelitis optica.
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition.
Oxidative modification of serum proteins in multiple sclerosis.
Uhthoff's phenomena in MS-clinical features and pathophysiology.
NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis (MIRROR)
Toxicity of Teriflunomide in Aryl Hydrocarbon Receptor Deficient Mice.
LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL.
Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS) (INSPIRE)
Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial.
Biogen Idec's long-acting beta interferon moves ahead in MS
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.
Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis (ITT-PMS)
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
A novel pH-sensitive interferon-β (INF-β) oral delivery system for application in multiple sclerosis.
Arzerra
The interplay between the intestinal microbiota and the brain.
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis

Pages